MedTrace Logo

Guangzhou Surveillance and Clinical Study in Microcephaly (GSCSM)

NCT03651687 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 47369

Last updated 2024-10-01

No results posted yet for this study

Summary

Screening for microcephaly is important at birth and during early childhood. The Guangzhou Surveillance and Clinical Study in Microcephaly (GSCSM) aims to establish a multicentric surveillance system for microcephaly in newborns and infants, to develop a new head circumference reference and microcephaly criteria basing on the local population in Guangzhou, to improve the prediction model of microcephaly, and to follow up the outcomes of the children diagnosed with microcephaly.

Conditions

  • Microcephaly

Interventions

OTHER

Sponsors & Collaborators

  • Guangzhou Huadu Women and Children Health Care Hospital

    collaborator UNKNOWN

  • Guangzhou Liwan Women and Children Health Care Hospital

    collaborator UNKNOWN

  • Institut Pasteur

    collaborator INDUSTRY

  • Guangzhou Women and Children's Medical Center

    lead OTHER

Principal Investigators

  • Xiu Qiu, MD,PhD · Guangzhou Women and Children's Medical Center, China

Eligibility

Max Age
24 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-10
Primary Completion
2024-09-27
Completion
2024-09-27

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03651687 on ClinicalTrials.gov